Related Experiment Video
Updated: Aug 14, 2026

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
DNA methylation aberrancies as a guide for surveillance and treatment of human cancers
Gangning Liang1, Daniel J Weisenberger2
1a Department of Urology , University of Southern California, USC Norris Comprehensive Cancer Center , Los Angeles , CA , USA.
Abstract:
DNA methylation aberrancies are hallmarks of human cancers and are characterized by global DNA hypomethylation of repetitive elements and non-CpG rich regions concomitant with locus-specific DNA hypermethylation. DNA methylation changes may result in altered gene expression profiles, most notably the silencing of tumor suppressors, microRNAs, endogenous retorviruses and tumor antigens due to promoter DNA hypermethylation, as well as oncogene upregulation due to gene-body DNA hypermethylation. Here, we review DNA methylation aberrancies in human cancers, their use in cancer surveillance and the interplay between DNA methylation and histone modifications in gene regulation. We also summarize DNA methylation inhibitors and their therapeutic effects in cancer treatment. In this context, we describe the integration of DNA methylation inhibitors with conventional chemotherapies, DNA repair inhibitors and immune-based therapies, to bring the epigenome closer to its normal state and increase sensitivity to other therapeutic agents to improve patient outcome and survival.
Insights
DNA methylation aberrancies drive human cancers through altered gene expression. DNA methylation inhibitors offer therapeutic potential, especially when combined with other cancer treatments to improve patient survival.
Area of Science:
- Epigenetics and Cancer Biology
- Molecular Oncology
- Genomic Instability
Background:
- DNA methylation aberrancies, including global hypomethylation and locus-specific hypermethylation, are key features of human cancers.
- These epigenetic changes can lead to altered gene expression, silencing tumor suppressors and activating oncogenes.
Purpose of the Study:
- To review DNA methylation aberrancies in human cancers.
- To explore the role of DNA methylation in cancer surveillance and gene regulation.
- To summarize the therapeutic potential of DNA methylation inhibitors in cancer treatment.
Main Methods:
- Review of existing literature on DNA methylation in cancer.
- Analysis of the interplay between DNA methylation and histone modifications.
- Summary of DNA methylation inhibitors and combination therapies.
Main Results:
- DNA methylation changes are linked to altered expression of tumor suppressors, microRNAs, and oncogenes.
- DNA methylation inhibitors show therapeutic effects and can be integrated with conventional therapies.
- Combination strategies aim to restore normal epigenome states and enhance treatment sensitivity.
Conclusions:
- DNA methylation plays a critical role in cancer development and progression.
- DNA methylation inhibitors represent a promising therapeutic strategy, particularly in combination regimens.
- Targeting the epigenome can improve patient outcomes and survival in cancer treatment.
Related Concept Videos
Epigenetic Regulation
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...

